Drugs / sodium carboxymethylcellulose
last change May 2026 re-read 2 minutes ago

sodium carboxymethylcellulose

Developed for
dry eye syndrome
Investigated by
Akorn, Inc. · Allergan · Koffler Vision Group · Superior University

Trials 3 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials
Phase 4 NCT02758327 Oct 2015 → Mar 2016 dry eye syndrome Koffler Vision Group Completed No outcome recorded
Phase 4 NCT02028754 Jul 2011 → May 2013 cataract, dry eye syndrome Allergan Completed No outcome recorded
Phase not applicable1 trial
NCT06913387 Mar → Jul 2025 overdue dry eye syndrome Superior University Active not recruiting No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT07372014 Background Jan → Mar 2026 overdue excessive tearing, stenosis of lacrimal punctum Instituto de Oftalmología Fundación Conde de Valenciana Active not recruiting No outcome recorded
Phase 4 NCT00797030 Background Oct 2006 → Jul 2008 dry eye syndrome Federal University of Rio de Janeiro Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Sodium carboxymethylcellulose “The intervention involved the administration of RECURO EYE DROPS, which contain Sodium carboxymethylcellulose 0.5%.” NCT06913387
4

sodium carboxymethylcellulose 0.5% (lubricant) three times daily for eight weeks” NCT07372014

“Sodium Carboxy-methylcellulose 0.25% eye Lubricant” NCT02758327

sodium carboxymethylcellulose 0.5% drops” NCT00797030

NCT02028754

Route Topical “sodium carboxymethylcellulose 0.5% drops” NCT00797030